{"id":20048,"date":"2024-08-09T15:57:17","date_gmt":"2024-08-09T15:57:17","guid":{"rendered":"https:\/\/beyondtype2.org\/resources\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/"},"modified":"2024-08-09T15:57:17","modified_gmt":"2024-08-09T15:57:17","slug":"medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/","title":{"rendered":"Medtronic anuncia la aprobaci\u00f3n por la FDA del MCG Simplera\u2122 y su asociaci\u00f3n global con Abbott"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">La Administraci&oacute;n de Alimentos y Medicamentos de los Estados Unidos (<\/span><i><span style=\"font-weight: 400;\">FDA, por sus siglas en ingl&eacute;s<\/span><\/i><span style=\"font-weight: 400;\">) aprob&oacute; el medidor continuo de glucosa (<\/span><i><span style=\"font-weight: 400;\">MCG<\/span><\/i><span style=\"font-weight: 400;\">) Simplera&trade; el 7 de agosto de 2024. Seg&uacute;n un <\/span><a href=\"https:\/\/news.medtronic.com\/2024-08-07-Medtronic-announces-FDA-approval-of-Simplera-TM-CGM-and-global-partnership-with-Abbott\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">comunicado de prensa de Medtronic, <\/span><\/a><span style=\"font-weight: 400;\">Simplera&trade; es el primer MCG todo en uno desechable de Medtronic y est&aacute; cambiando la forma en que las personas manejan la diabetes, ya que:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">su tama&ntilde;o es compacto;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">es f&aacute;cil de usar;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">elimina la necesidad de colocar un parche adhesivo.<\/span><\/li>\n<\/ul>\n<h3><b><i>El MCG Simplera&trade;: un punto de inflexi&oacute;n en el manejo de la diabetes<\/i><\/b><\/h3>\n<p><span style=\"font-weight: 400;\">La plataforma Simplera&trade; presenta una nueva era en <\/span><a href=\"https:\/\/beyondtype1.org\/es\/tabla-mcg-beyond-type-1\/\"><span style=\"font-weight: 400;\">tecnolog&iacute;a MCG<\/span><\/a><span style=\"font-weight: 400;\"> con su dise&ntilde;o discreto y simplificado.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La plataforma incluye dos componentes clave:<\/span><\/p>\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>El MCG Simplera&trade;<\/b><span style=\"font-weight: 400;\">: Con la <\/span><a href=\"https:\/\/beyondtype1.org\/es\/resena-inpen\/\"><span style=\"font-weight: 400;\">pluma de insulina conectada (&ldquo;inteligente&rdquo;) InPen&trade;<\/span><\/a><span style=\"font-weight: 400;\">, este MCG avanzado se puede utilizar para crear un sistema inteligente de Smart MDI (inyecciones diarias m&uacute;ltiples). Ofrece una experiencia de inserci&oacute;n y uso optimizada, lo que hace que el manejo de la diabetes sea m&aacute;s conveniente.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>El sensor Simplera Sync&trade;<\/b><span style=\"font-weight: 400;\">: Este sensor se dise&ntilde;&oacute; para la integraci&oacute;n con el <\/span><a href=\"https:\/\/beyondtype1.org\/es\/minimed-780g-medtronic-aprobacion-fda\/\"><span style=\"font-weight: 400;\">sistema MiniMed&trade; 780G<\/span><\/a><span style=\"font-weight: 400;\"> y complementa los altos niveles de satisfacci&oacute;n existentes del sistema MiniMed&trade; 780G, que ha recibido comentarios positivos en Europa.<\/span><\/li>\n<\/ol>\n<h3><b><i>La aprobaci&oacute;n de la FDA abre las puertas<\/i><\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Esta aprobaci&oacute;n abre la puerta para que en el futuro se presente la aplicaci&oacute;n m&oacute;vil de la pluma de insulina inteligente InPen&trade; mejorada.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tambi&eacute;n facilita la integraci&oacute;n del InPen&trade; con el MCG Simplera&trade; como parte de un sistema Smart MDI con todo incluido.<\/span><\/p>\n<h3><b><i>Asociaci&oacute;n global estrat&eacute;gica con Abbott<\/i><\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Con la iniciativa de ampliar a&uacute;n m&aacute;s su oferta de MCG, Medtronic tambi&eacute;n ha anunciado una asociaci&oacute;n global con <\/span><a href=\"https:\/\/www.diabetescare.abbott\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Abbott<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Abbott le proporcionar&aacute; a Medtronic un MCG dise&ntilde;ado espec&iacute;ficamente para funcionar con el software y el equipo de dosificaci&oacute;n inteligente de Medtronic tanto para Smart MDI como para <\/span><a href=\"https:\/\/beyondtype1.org\/es\/kiley-luckett-sistema-administracion-automatica-insulina-salud-mental\/\"><span style=\"font-weight: 400;\">sistemas automatizados de administraci&oacute;n de insulina<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Con esta asociaci&oacute;n, Medtronic vender&aacute; exclusivamente sistemas que incorporen el MCG de Abbott.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">&ldquo;Nuestra asociaci&oacute;n con Abbott nos permite ampliar el acceso a nuestros avanzados sistemas automatizados de administraci&oacute;n de insulina y Smart MDI que ofrecen los mejores resultados con el MCG m&aacute;s utilizado en el mundo&rdquo;, dijo Que Dallara, vicepresidenta ejecutiva y presidenta de Medtronic Diabetes. &ldquo;Esperamos ofrecer nuestra plataforma Simplera&trade; junto con este MCG integrado para brindar m&aacute;s opciones a las personas que viven con diabetes dentro de una experiencia perfecta de Medtronic&rdquo;.<\/span><\/p>\n<h3><b><i>Integraci&oacute;n futura<\/i><\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Medtronic piensa iniciar un lanzamiento limitado al mercado de EE. UU., comenzando con los clientes independientes existentes de MCG e InPen&trade;.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Mientras tanto, el sensor Simplera Sync&trade; est&aacute; bajo revisi&oacute;n regulatoria por separado por parte de la FDA y en la actualidad est&aacute; en fase de investigaci&oacute;n en los EE. UU.<\/span><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>La Administraci&oacute;n de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en ingl&eacute;s) aprob&oacute; el medidor continuo de glucosa (MCG) Simplera&trade; el 7 de agosto de 2024. Seg&uacute;n un comunicado de prensa de Medtronic, Simplera&trade; es el primer MCG todo en uno desechable de Medtronic y est&aacute; cambiando la forma en que [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":20050,"comment_status":"open","ping_status":"open","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-20048","resources","type-resources","status-publish","has-post-thumbnail","hentry","diabetes-types-tipo-1","tags-new_home_latest"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medtronic anuncia la aprobaci\u00f3n por la FDA del MCG Simplera\u2122 y su asociaci\u00f3n global con Abbott | Beyond Type 1<\/title>\n<meta name=\"description\" content=\"El MCG Simplera\u2122, aprobado por la FDA el 7 de agosto de 2024, ofrece un dise\u00f1o compacto todo en uno, revolucionando el manejo de la diabetes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medtronic anuncia la aprobaci\u00f3n por la FDA del MCG Simplera\u2122 y su asociaci\u00f3n global con Abbott | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"El MCG Simplera\u2122, aprobado por la FDA el 7 de agosto de 2024, ofrece un dise\u00f1o compacto todo en uno, revolucionando el manejo de la diabetes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-MEDTRONIC-FDEA-APPROVAL-OF-SIMPLERA-HEADER-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"733\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\\\/\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\\\/\",\"name\":\"Medtronic anuncia la aprobaci\u00f3n por la FDA del MCG Simplera\u2122 y su asociaci\u00f3n global con Abbott | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/BT1-MEDTRONIC-FDEA-APPROVAL-OF-SIMPLERA-HEADER-2.png\",\"datePublished\":\"2024-08-09T15:57:17+00:00\",\"description\":\"El MCG Simplera\u2122, aprobado por la FDA el 7 de agosto de 2024, ofrece un dise\u00f1o compacto todo en uno, revolucionando el manejo de la diabetes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/beyondtype1.org\\\/es\\\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\\\/#primaryimage\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/BT1-MEDTRONIC-FDEA-APPROVAL-OF-SIMPLERA-HEADER-2.png\",\"contentUrl\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/BT1-MEDTRONIC-FDEA-APPROVAL-OF-SIMPLERA-HEADER-2.png\",\"width\":2048,\"height\":733},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medtronic anuncia la aprobaci\u00f3n por la FDA del MCG Simplera\u2122 y su asociaci\u00f3n global con Abbott\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/header-logo.svg\",\"contentUrl\":\"https:\\\/\\\/beyondtype1.org\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\\\/\\\/beyondtype1.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/beyondtype1\",\"https:\\\/\\\/x.com\\\/BeyondType1\",\"http:\\\/\\\/instagram.com\\\/BeyondType1\\\/\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/BeyondType1\",\"https:\\\/\\\/www.tiktok.com\\\/@beyondtype1\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/beyond-type1\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medtronic anuncia la aprobaci\u00f3n por la FDA del MCG Simplera\u2122 y su asociaci\u00f3n global con Abbott | Beyond Type 1","description":"El MCG Simplera\u2122, aprobado por la FDA el 7 de agosto de 2024, ofrece un dise\u00f1o compacto todo en uno, revolucionando el manejo de la diabetes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/","og_locale":"es_ES","og_type":"article","og_title":"Medtronic anuncia la aprobaci\u00f3n por la FDA del MCG Simplera\u2122 y su asociaci\u00f3n global con Abbott | Beyond Type 1","og_description":"El MCG Simplera\u2122, aprobado por la FDA el 7 de agosto de 2024, ofrece un dise\u00f1o compacto todo en uno, revolucionando el manejo de la diabetes.","og_url":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","og_image":[{"width":2048,"height":733,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-MEDTRONIC-FDEA-APPROVAL-OF-SIMPLERA-HEADER-2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/","url":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/","name":"Medtronic anuncia la aprobaci\u00f3n por la FDA del MCG Simplera\u2122 y su asociaci\u00f3n global con Abbott | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-MEDTRONIC-FDEA-APPROVAL-OF-SIMPLERA-HEADER-2.png","datePublished":"2024-08-09T15:57:17+00:00","description":"El MCG Simplera\u2122, aprobado por la FDA el 7 de agosto de 2024, ofrece un dise\u00f1o compacto todo en uno, revolucionando el manejo de la diabetes.","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-MEDTRONIC-FDEA-APPROVAL-OF-SIMPLERA-HEADER-2.png","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-MEDTRONIC-FDEA-APPROVAL-OF-SIMPLERA-HEADER-2.png","width":2048,"height":733},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/medtronic-aprobacion-fda-mcg-simplera-asociacion-abbott\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"Medtronic anuncia la aprobaci\u00f3n por la FDA del MCG Simplera\u2122 y su asociaci\u00f3n global con Abbott"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/20048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=20048"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/20048\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/20050"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=20048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}